MakeMyTrip: Positive On Planned Indian Listing And Operational Resilience
Source: seekingalpha.com

MakeMyTrip remains rated Buy as a planned IPO of its Indian subsidiary could unlock value, finance convertible-note redemptions, and reduce its valuation discount versus domestic peers. Diversified exposure to hotels and bus bookings is expected to offset air-ticketing headwinds while supporting continued improvement in take rates.
Analysis
The key re-rating mechanism is less the operating mix than capital-structure simplification: a separately valued Indian asset could create a clearer NAV anchor and reduce the discount applied to MMYT's offshore holding-company structure. The upside depends on whether proceeds are used to retire converts rather than fund aggressive customer-acquisition spend; deleveraging/removal of dilution overhang would support both equity value and the earnings multiple. Until filing documents establish the stake sold, use of proceeds, related-party arrangements, and governance rights retained by MMYT, the implied sum-of-the-parts discount is not independently verifiable.
Near term, MMYT is vulnerable to a "sell-the-news" reaction if the transaction timeline slips or the subsidiary is priced at a discount to Indian online-travel comparables. Over 1-3 months, draft prospectus disclosure on segment profitability, hotel take-rate durability, marketing intensity, and working-capital requirements is the primary catalyst; these data determine whether ancillary categories merit a premium multiple or merely mask cyclicality in air. Over 6-18 months, the structural risk is local competitors using IPO proceeds and lower domestic funding costs to bid up distribution and supplier incentives, compressing hotel and ground-transport economics.
Contrarian view: the proposed listing may be less accretive than headline NAV math implies. Minority public investors can demand a governance discount for an operating subsidiary controlled by a foreign-listed parent, while dual-listing costs and restricted cash flows can leave MMYT shareholders without a clean route to realizing the subsidiary's quoted value. The thesis is falsified if the filing indicates limited debt/convertible retirement, materially higher sales-and-marketing intensity, or a valuation below comparable Indian consumer-internet IPOs.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
Ticker Sentiment
Key Decisions for Investors
- Maintain a modest long MMYT only ahead of a formal filing or transaction announcement; size as an event-driven position rather than a core travel allocation. Target a 10-15% re-rating if disclosed subsidiary valuation and retained ownership imply a material discount to MMYT enterprise value; cut if the stock falls 12% below entry without a filing catalyst or if timing moves beyond two reporting periods.
- Do not underwrite the convertible-redemption benefit until management discloses outstanding principal, conversion terms, redemption funding, and post-transaction share count. Establish an alert for these items in the prospectus; absent them, treat any rally as multiple expansion rather than demonstrated per-share value creation.
- At the next earnings release, focus on hotel/ground segment contribution margin and sales-and-marketing as a percentage of gross bookings. A sustained increase in take rate alongside stable marketing intensity supports adding over the following 1-3 months; a margin deterioration despite growth would favor reducing exposure.
- For hedge-fund portfolios with India access, consider a catalyst pair of long MMYT versus a basket of Indian online-travel peers only after IPO terms are public. The pair isolates holding-company-discount closure; exit if the subsidiary's indicated valuation does not exceed MMYT's embedded valuation by at least 20% after applying a governance discount.
More News
- Exclusive-Malaysia talks to rival airlines as it monitors AirAsia’s financial health, sources say
- Australia’s Reliance Worldwide agrees to Brookfield’s $2.9 billion buyout bid
- Trip.com swings to Q2 loss after $763 million antitrust penalty
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Saudi-led coalition intercepts drone headed for Mecca
- Reliance Worldwide shares hit 1-year high on Brookfield’s $2.9 bln deal